Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 3
Submit an article Journal homepage
163
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluations

Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1

Patricia Moretto The Margaret and Charles Juravinski Cancer Centre Department of Oncology, 699 Concession Street, Hamilton, ON, L8V 5C2, Canada, USA +1 905 387 9495, ext. 64605; +1 905 575 6326; [email protected]
&
Sébastien J Hotte The Margaret and Charles Juravinski Cancer Centre Department of Oncology, 699 Concession Street, Hamilton, ON, L8V 5C2, Canada, USA +1 905 387 9495, ext. 64605; +1 905 575 6326; [email protected]
, MD MSc (HRM) FRCPC
Pages 311-325 | Published online: 09 May 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.